市場調査レポート

商品コード

遅発性ジスキネジア治療の世界市場 2025-2029

Global Tardive Dyskinesia Treatment Market 2025-2029

出版日: 2025年07月22日
発行: TechNavio
ページ情報: 英文 198 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 379,475円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 607,160円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=151.79円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

遅発性ジスキネジア治療市場は2024-2029年に7億2,840万米ドル、予測期間中のCAGRは4.6%で成長すると予測されます。

当レポートでは、遅発性ジスキネジア治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、精神障害患者の増加、抗精神病薬処方の増加、神経疾患治療に対する膨大なアンメットニーズによって牽引されています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比	4.4%
CAGR	4.6%
増分額	7億2,840万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、遅発性ジスキネジア治療に関する認知を広める取り組みが、今後数年間の遅発性ジスキネジア治療市場の成長を促進する主要な理由の1つであると特定しています。また、遅発性ジスキネジア治療に対する規制当局の承認が進み、製薬企業による研究資金が増加していることも、市場の大きな需要につながると思われます。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2024-2029
欧州：市場規模と予測 2024-2029
アジア：市場規模と予測 2024-2029
世界のその他の地域：市場規模と予測 2024-2029
米国：市場規模と予測 2024-2029
中国：市場規模と予測 2024-2029
ドイツ：市場規模と予測 2024-2029
英国：市場規模と予測 2024-2029
日本：市場規模と予測 2024-2029
フランス：市場規模と予測 2024-2029
インド：市場規模と予測 2024-2029
カナダ：市場規模と予測 2024-2029
韓国：市場規模と予測 2024-2029
イタリア：市場規模と予測 2024-2029
市場機会：地域情勢別

第13章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第14章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第15章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
Abbott Laboratories
Alembic Pharmaceuticals Ltd.
Aspire Pharma Ltd.
Centaur Pharmaceuticals Pvt. Ltd.
Cipla Inc.
Lannett Co Inc.
Luye Pharma Group Ltd.
Neurocrine Biosciences Inc.
Novartis AG
Psicofarma S. A. de C. V
Sawai Group Holdings Co. Ltd.
SOM Innovation Biotech S.A.
SteriMax Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

第16章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Tardive Dyskinesia Treatment Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on End-user - Market share 2024-2029 (%)
Exhibits39: Data Table on End-user - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by End-user
Exhibits41: Data Table on Comparison by End-user
Exhibits42: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by End-user ($ million)
Exhibits55: Data Table on Market opportunity by End-user ($ million)
Exhibits56: Chart on Product - Market share 2024-2029 (%)
Exhibits57: Data Table on Product - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Product
Exhibits59: Data Table on Comparison by Product
Exhibits60: Chart on Austedo and Ingrezza - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Austedo and Ingrezza - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Austedo and Ingrezza - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Austedo and Ingrezza - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits68: Market opportunity by Product ($ million)
Exhibits69: Data Table on Market opportunity by Product ($ million)
Exhibits70: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits71: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits72: Chart on Comparison by Route of Administration
Exhibits73: Data Table on Comparison by Route of Administration
Exhibits74: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits75: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits76: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits77: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits78: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits82: Market opportunity by Route of Administration ($ million)
Exhibits83: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits85: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits86: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits87: Chart on Geographic comparison
Exhibits88: Data Table on Geographic comparison
Exhibits89: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits145: Market opportunity By Geographical Landscape ($ million)
Exhibits146: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits147: Impact of drivers and challenges in 2024 and 2029
Exhibits148: Overview on criticality of inputs and factors of differentiation
Exhibits149: Overview on factors of disruption
Exhibits150: Impact of key risks on business
Exhibits151: Companies covered
Exhibits152: Company ranking index
Exhibits153: Matrix on companies position and classification
Exhibits154: Abbott Laboratories - Overview
Exhibits155: Abbott Laboratories - Business segments
Exhibits156: Abbott Laboratories - Key news
Exhibits157: Abbott Laboratories - Key offerings
Exhibits158: Abbott Laboratories - Segment focus
Exhibits159: SWOT
Exhibits160: Alembic Pharmaceuticals Ltd. - Overview
Exhibits161: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibits162: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits163: SWOT
Exhibits164: Aspire Pharma Ltd. - Overview
Exhibits165: Aspire Pharma Ltd. - Product / Service
Exhibits166: Aspire Pharma Ltd. - Key offerings
Exhibits167: SWOT
Exhibits168: Centaur Pharmaceuticals Pvt. Ltd. - Overview
Exhibits169: Centaur Pharmaceuticals Pvt. Ltd. - Product / Service
Exhibits170: Centaur Pharmaceuticals Pvt. Ltd. - Key offerings
Exhibits171: SWOT
Exhibits172: Cipla Inc. - Overview
Exhibits173: Cipla Inc. - Business segments
Exhibits174: Cipla Inc. - Key news
Exhibits175: Cipla Inc. - Key offerings
Exhibits176: Cipla Inc. - Segment focus
Exhibits177: SWOT
Exhibits178: Lannett Co Inc. - Overview
Exhibits179: Lannett Co Inc. - Product / Service
Exhibits180: Lannett Co Inc. - Key offerings
Exhibits181: SWOT
Exhibits182: Luye Pharma Group Ltd. - Overview
Exhibits183: Luye Pharma Group Ltd. - Business segments
Exhibits184: Luye Pharma Group Ltd. - Key offerings
Exhibits185: Luye Pharma Group Ltd. - Segment focus
Exhibits186: SWOT
Exhibits187: Neurocrine Biosciences Inc. - Overview
Exhibits188: Neurocrine Biosciences Inc. - Product / Service
Exhibits189: Neurocrine Biosciences Inc. - Key offerings
Exhibits190: SWOT
Exhibits191: Novartis AG - Overview
Exhibits192: Novartis AG - Business segments
Exhibits193: Novartis AG - Key news
Exhibits194: Novartis AG - Key offerings
Exhibits195: Novartis AG - Segment focus
Exhibits196: SWOT
Exhibits197: Psicofarma S. A. de C. V - Overview
Exhibits198: Psicofarma S. A. de C. V - Product / Service
Exhibits199: Psicofarma S. A. de C. V - Key offerings
Exhibits200: SWOT
Exhibits201: Sawai Group Holdings Co. Ltd. - Overview
Exhibits202: Sawai Group Holdings Co. Ltd. - Product / Service
Exhibits203: Sawai Group Holdings Co. Ltd. - Key offerings
Exhibits204: SWOT
Exhibits205: SOM Innovation Biotech S.A. - Overview
Exhibits206: SOM Innovation Biotech S.A. - Product / Service
Exhibits207: SOM Innovation Biotech S.A. - Key offerings
Exhibits208: SWOT
Exhibits209: SteriMax Inc. - Overview
Exhibits210: SteriMax Inc. - Product / Service
Exhibits211: SteriMax Inc. - Key offerings
Exhibits212: SWOT
Exhibits213: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits214: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits215: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits216: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits217: SWOT
Exhibits218: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits219: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits220: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits221: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits222: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits223: SWOT
Exhibits224: Inclusions checklist
Exhibits225: Exclusions checklist
Exhibits226: Currency conversion rates for US$
Exhibits227: Research methodology
Exhibits228: Information sources
Exhibits229: Data validation
Exhibits230: Validation techniques employed for market sizing
Exhibits231: Data synthesis
Exhibits232: 360 degree market analysis
Exhibits233: List of abbreviations

Product Code: IRTNTR76758

The tardive dyskinesia treatment market is forecasted to grow by USD 728.4 mn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the tardive dyskinesia treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cases of mental disorders, growing antipsychotic prescription, and huge unmet need for neurological disease treatments.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	4.4%
CAGR	4.6%
Incremental Value	$728.4 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's tardive dyskinesia treatment market is segmented as below:

By End-user

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Product

Austedo and Ingrezza
Others

By Route Of Administration

Oral
Injectable

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the initiatives to spread awareness regarding treatment of tardive dyskinesia as one of the prime reasons driving the tardive dyskinesia treatment market growth during the next few years. Also, growing regulatory approval for treating tardive dyskinesia and increasing research funding by pharmaceutical companies will lead to sizable demand in the market.

The report on the tardive dyskinesia treatment market covers the following areas:

Tardive Dyskinesia Treatment Market sizing
Tardive Dyskinesia Treatment Market forecast
Tardive Dyskinesia Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tardive dyskinesia treatment market vendors that include Abbott Laboratories, Actiza Pharmaceutical Pvt. Ltd., Alembic Pharmaceuticals Ltd., Aspire Pharma Ltd., Centaur Pharmaceuticals Pvt. Ltd., Cipla Inc., Hetero Labs Ltd., Lannett Co Inc., Luye Pharma Group Ltd., Neurocrine Biosciences Inc., Novartis AG, Psicofarma S. A. de C. V, Ryon pharma, Sawai Group Holdings Co. Ltd., Slate Run Pharmaceuticals LLC, Solco Healthcare, SOM Innovation Biotech S.A., SteriMax Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the tardive dyskinesia treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Tardive Dyskinesia Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Tardive Dyskinesia Treatment Market 2019 - 2023 ($ million)
5.2 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.3 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The impact of AI in the global tardive dyskinesia treatment market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
8.3 Hospital pharmacy - Market size and forecast 2024-2029
- Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
8.4 Retail pharmacy - Market size and forecast 2024-2029
- Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
8.5 Online pharmacy - Market size and forecast 2024-2029
- Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Product

9.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
9.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
9.3 Austedo and Ingrezza - Market size and forecast 2024-2029
- Chart on Austedo and Ingrezza - Market size and forecast 2024-2029 ($ million)
- Data Table on Austedo and Ingrezza - Market size and forecast 2024-2029 ($ million)
- Chart on Austedo and Ingrezza - Year-over-year growth 2024-2029 (%)
- Data Table on Austedo and Ingrezza - Year-over-year growth 2024-2029 (%)
9.4 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.4 Injectable - Market size and forecast 2024-2029
- Chart on Injectable - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.14 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.15 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Alembic Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Ltd. - Overview
- Alembic Pharmaceuticals Ltd. - Product / Service
- Alembic Pharmaceuticals Ltd. - Key offerings
- SWOT
15.6 Aspire Pharma Ltd.
- Aspire Pharma Ltd. - Overview
- Aspire Pharma Ltd. - Product / Service
- Aspire Pharma Ltd. - Key offerings
- SWOT
15.7 Centaur Pharmaceuticals Pvt. Ltd.
- Centaur Pharmaceuticals Pvt. Ltd. - Overview
- Centaur Pharmaceuticals Pvt. Ltd. - Product / Service
- Centaur Pharmaceuticals Pvt. Ltd. - Key offerings
- SWOT
15.8 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
15.9 Lannett Co Inc.
- Lannett Co Inc. - Overview
- Lannett Co Inc. - Product / Service
- Lannett Co Inc. - Key offerings
- SWOT
15.10 Luye Pharma Group Ltd.
- Luye Pharma Group Ltd. - Overview
- Luye Pharma Group Ltd. - Business segments
- Luye Pharma Group Ltd. - Key offerings
- Luye Pharma Group Ltd. - Segment focus
- SWOT
15.11 Neurocrine Biosciences Inc.
- Neurocrine Biosciences Inc. - Overview
- Neurocrine Biosciences Inc. - Product / Service
- Neurocrine Biosciences Inc. - Key offerings
- SWOT
15.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.13 Psicofarma S. A. de C. V
- Psicofarma S. A. de C. V - Overview
- Psicofarma S. A. de C. V - Product / Service
- Psicofarma S. A. de C. V - Key offerings
- SWOT
15.14 Sawai Group Holdings Co. Ltd.
- Sawai Group Holdings Co. Ltd. - Overview
- Sawai Group Holdings Co. Ltd. - Product / Service
- Sawai Group Holdings Co. Ltd. - Key offerings
- SWOT
15.15 SOM Innovation Biotech S.A.
- SOM Innovation Biotech S.A. - Overview
- SOM Innovation Biotech S.A. - Product / Service
- SOM Innovation Biotech S.A. - Key offerings
- SWOT
15.16 SteriMax Inc.
- SteriMax Inc. - Overview
- SteriMax Inc. - Product / Service
- SteriMax Inc. - Key offerings
- SWOT
15.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.18 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

遅発性ジスキネジア治療の世界市場 2025-2029

Global Tardive Dyskinesia Treatment Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：エンドユーザー別

第9章市場セグメンテーション：製品別

第10章市場セグメンテーション：投与経路別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by End-user

9 Market Segmentation by Product

10 Market Segmentation by Route of Administration

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

遅発性ジスキネジア治療の世界市場 2025-2029

Global Tardive Dyskinesia Treatment Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：エンドユーザー別

第9章 市場セグメンテーション：製品別

第10章 市場セグメンテーション：投与経路別

第11章 顧客情勢

第12章 地域別情勢

第13章 促進要因・課題・機会・抑制要因

第14章 競合情勢

第15章 競合分析

第16章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by End-user

9 Market Segmentation by Product

10 Market Segmentation by Route of Administration

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：エンドユーザー別

第9章市場セグメンテーション：製品別

第10章市場セグメンテーション：投与経路別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録